U.S. Oil Companies Look to Benefit as West Texas Intermediate Crude Oil Prices Continues to Rise

The Paragon Report Provides Stock Research on Cabot Oil & Gas and Whiting Petroleum

Continue Reading

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on ACADIA Pharmaceuticals and Halozyme Therapeutics

Continue Reading

Over the Next 5 Years Global Coal Demand to Increase at an Average of 2.6% a Year

The Paragon Report Provides Stock Research on Cloud Peak Energy and Walter Energy

Continue Reading

Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Five Star Equities Provides Stock Research on Keryx Biopharmaceuticals and Novavax

Continue Reading

Natural Gas Futures Have Fallen Nearly 20 Percent From 12-Month High in November

Five Star Equities Provides Stock Research on Apache and Linn Energy

Continue Reading

Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Five Star Equities Provides Stock Research on AEterna Zentaris and BioCryst Pharmaceuticals

Continue Reading

Margin Between U.S. and Europe Oil Benchmarks Narrowest in Over Three-Months

The Paragon Report Provides Stock Research on Swift Energy and ZaZa Energy

Continue Reading

Ample Supplies and Falling Heating Demand Creates Bearish Outlook for Natural Gas

Five Star Equities Provides Stock Research on Anadarko Petroleum and Devon Energy

Continue Reading

Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Five Star Equities Provides Stock Research on Neuralstem and Idenix Pharmaceuticals

Continue Reading

Natural Gas Rally Ends as Heating Demand Expected to Experience a Steep Decline

Five Star Equities Provides Stock Research on Southwestern Energy and Ultra Petroleum

Continue Reading